Alkan, A. Et Al. 2015. First-Line Crizotinib in ALK-Positive Lung Cancer. NEW ENGLAND JOURNAL OF MEDICINE , vol.372, no.8 , 781-782.

Alkan, A., KÖKSOY, E. B., & UTKAN, G., (2015). First-Line Crizotinib in ALK-Positive Lung Cancer. NEW ENGLAND JOURNAL OF MEDICINE , vol.372, no.8, 781-782.

Alkan, Ali, ELİF BERNA KÖKSOY, And GÜNGÖR UTKAN. "First-Line Crizotinib in ALK-Positive Lung Cancer," NEW ENGLAND JOURNAL OF MEDICINE , vol.372, no.8, 781-782, 2015

Alkan, Ali Et Al. "First-Line Crizotinib in ALK-Positive Lung Cancer." NEW ENGLAND JOURNAL OF MEDICINE , vol.372, no.8, pp.781-782, 2015

Alkan, A. KÖKSOY, E. B. And UTKAN, G. (2015) . "First-Line Crizotinib in ALK-Positive Lung Cancer." NEW ENGLAND JOURNAL OF MEDICINE , vol.372, no.8, pp.781-782.

@article{article, author={Ali Alkan Et Al. }, title={First-Line Crizotinib in ALK-Positive Lung Cancer}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2015, pages={781-782} }